The investigation, published in BMC Complementary Medicine and Therapies, was led by pharmacognosy researcher Amal M. El-Feky, together with Noha E. Ibrahim and Wael Mahmoud Aboulthana, all based at the National Research Centre in Giza. The team collected leaves from a private farm in Wadi El-Natron, in Egypt’s El-Behera Governorate, with the farm owner’s permission and in accordance with local regulations. Rather than sampling a single moment in the growing season, the researchers deliberately built a temporal comparison into the experimental design, reasoning that a grapevine leaf is not a static repository of chemicals but a living tissue whose metabolic output shifts as the plant moves through budbreak, flowering, fruit set, and ripening. That seasonal logic proved correct in striking fashion.

The analytical work began with the most visible layer of leaf chemistry: the photosynthetic pigments. Total chlorophyll peaked in the May harvest, coinciding with the vine’s peak vegetative vigor, while carotenoids—the accessory pigments that help plants dissipate excess light energy—were comparatively higher in the September and March samples. This split is biologically meaningful. Chlorophyll accumulation tracks the leaf’s investment in photosynthetic machinery during active growth, whereas elevated carotenoid levels in the shoulder seasons may reflect protective responses to cooler temperatures and changing light regimes. For anyone hoping to extract pigments or pigment-derived compounds from vine leaves, the data imply that the target molecule should dictate the calendar: chlorophyll seekers should head for the vineyard in late spring, while carotenoid-focused work might do better in early autumn.

Pigments, however, were only the opening act. The heart of the study lay in the secondary metabolites—the phenolic compounds, flavonoids, and tannins that plants synthesize not for photosynthesis but for defense, signaling, and stress tolerance. Using methanolic extracts of the leaves, the researchers quantified total polyphenols, flavonoids, and tannins at each harvest point and found a consistent pattern: the May samples dominated all three categories. This matters because phenolic compounds are the principal drivers of the antioxidant and anti-inflammatory effects attributed to grape leaf extracts in traditional medicine and in modern nutraceutical research. A harvest window that concentrates these molecules effectively multiplies the value of an agricultural stream that would otherwise be discarded.

To move beyond bulk measurements, the team turned to high-performance liquid chromatography, a technique that separates a crude extract into its individual constituents and allows each to be identified and quantified. The HPLC profiles confirmed what the totals had hinted at: the May extract carried a markedly richer load of phenolic and flavonoid constituents than the March or September samples. Among the predominant compounds were chlorogenic acid, rosmarinic acid, gallic acid, and naringenin—a chemically diverse quartet spanning hydroxycinnamic acids, hydroxybenzoic acids, and a flavanone. Each of these molecules has an established research pedigree. Chlorogenic acid is a well-known antioxidant and glucose-modulating agent, rosmarinic acid carries anti-inflammatory credentials, gallic acid is a reference-standard radical scavenger, and naringenin has been studied for effects ranging from lipid metabolism to cytoprotection. The researchers went a step further by isolating the major compounds and structurally identifying them, anchoring the chromatographic assignments in purified material.

With the chemistry mapped, the study pivoted to function. The extracts were subjected to antioxidant and radical-scavenging assays, which measure a sample’s capacity to neutralize reactive oxygen species—unstable molecules that damage lipids, proteins, and DNA and are implicated in aging, inflammation, and chronic disease. Here the May extract again led the field, an outcome that tracks directly with its superior phenolic content, since phenolic hydroxyl groups donate electrons or hydrogen atoms to quench radicals. The correlation between total polyphenol content and antioxidant capacity is one of the most reproducible relationships in natural products research, and this study adds another clean data point to that canon.

The therapeutic screening went considerably further than antioxidant chemistry. In antidiabetic assays, the extracts were tested for their ability to inhibit the carbohydrate-digesting enzymes that determine post-meal glucose spikes, a mechanism shared by several licensed antidiabetic drugs. In anti-Alzheimer’s assays, the focus shifted to enzymes such as acetylcholinesterase, whose inhibition can help preserve the neurotransmitter signaling that degenerates in dementia. Anti-inflammatory and anti-arthritic assays probed the extracts’ capacity to blunt protein denaturation and inflammatory mediators relevant to joint disease, while cytotoxicity testing evaluated the extracts against human cancer cell lines—work conducted under the approval of the Medical Research Ethics Committee of the National Research Centre, under protocol number 04431024. Across this entire panel, the May extract delivered the strongest inhibitory effects, outperforming the March and September samples in every category.

The coherence of the results is what gives the study its force. It is one thing for a single assay to favor one extract; it is another for pigment data, bulk phytochemical quantification, chromatographic profiling, and six distinct bioactivity screens to converge on the same conclusion. That convergence suggests a genuine biological phenomenon rather than a statistical fluke: the vine leaf in May is, in chemical terms, a different object from the same leaf in March or September. The likely drivers are seasonal shifts in the plant’s physiology—peak photosynthetic activity, active growth, and the metabolic demands of flowering and early fruit development—which channel carbon into phenylpropanoid and flavonoid biosynthesis. Environmental variables such as temperature, solar radiation, and water availability in the Wadi El-Natron region during late spring plausibly reinforce this metabolic surge.

The practical implications extend well beyond the laboratory bench. Grape leaves are an abundant, low-cost by-product of viticulture, generated in large volumes during canopy management and harvest worldwide. If processors know that a May harvest—or, more realistically, leaf material collected around the equivalent phenological stage in any given climate—yields extracts with maximal bioactive content, vineyard waste becomes a feedstock for nutraceuticals, cosmeceuticals, and functional food ingredients. The authors frame this explicitly as a valorization opportunity: converting an underused residue into value-added products. The finding also carries a methodological lesson for the wider field of medicinal plant research, where studies routinely report phytochemical data without specifying harvest timing, or compare extracts from batches collected at inconsistent times. If composition can swing this widely within a single growing season, harvest date belongs alongside species, organ, and extraction solvent as a non-negotiable variable in any serious phytochemical study.

Caveats remain, and the authors are careful about scope. All of the bioactivity findings are in vitro—performed in test tubes, enzyme solutions, and cell cultures—so they demonstrate mechanistic potential rather than clinical efficacy. Whether May-harvested grape leaf extracts translate into meaningful antioxidant, antidiabetic, or anti-inflammatory effects in humans will require bioavailability studies, safety profiling, and eventually controlled trials. Dose, formulation, and the identity of the active compounds in vivo all remain open questions. Still, as a piece of applied natural products chemistry, the study lands cleanly: it identifies a specific, actionable harvest window, backs it with layered analytical and bioactivity evidence, and points the way toward turning one of agriculture’s most familiar leftovers into a genuinely useful resource. For the grapevine, it seems, the calendar is not just a farming tool—it is a chemistry lesson.

Subject of Research: Seasonal variation in the phytochemistry and in vitro bioactivities of grapevine (Vitis vinifera) leaves

Article Title: Harvest-Time–Dependent variations in phytochemistry and in vitro bioactivities of Vitis vinifera Leaves

Article References: Harvest-Time–Dependent variations in phytochemistry and in vitro bioactivities of Vitis vinifera Leaves. (n.d.). https://doi.org/10.1186/s12906-026-05578-x

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05578-x

Keywords: Vitis vinifera, grape leaves, polyphenols, flavonoids, harvest time, phytochemistry, antioxidant activity, antidiabetic, anti-inflammatory, cytotoxicity, HPLC, viticulture by-products